Cargando…
The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
Autores principales: | Phillips, Patrick PJ, Crook, Angela, Nunn, Andrew J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287746/ http://dx.doi.org/10.1186/1745-6215-12-S1-A31 |
Ejemplares similares
-
Alternative approaches to tuberculosis treatment evaluation: the role of pragmatic trials
por: Bratton, Daniel J, et al.
Publicado: (2011) -
Rethinking intercurrent events in defining estimands for tuberculosis trials
por: Pham, Tra My, et al.
Publicado: (2022) -
Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
por: Wangge, Grace, et al.
Publicado: (2011) -
An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011) -
A multi-arm multi-stage design for binary outcomes and application to tuberculosis
por: Bratton, Daniel, et al.
Publicado: (2013)